≡

ELISA Kit for Matrix Metalloproteinase 17 (MMP17)

MT4-MMP; MMP4; Membrane-type matrix metalloproteinase 4; Membrane-type-4 matrix metalloproteinase

Specificity

This assay has high sensitivity and excellent specificity for detection of Matrix Metalloproteinase 17 (MMP17).
No significant cross-reactivity or interference between Matrix Metalloproteinase 17 (MMP17) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Matrix Metalloproteinase 17 (MMP17) and the recovery rates were calculated by comparing the measured value to the expected amount of Matrix Metalloproteinase 17 (MMP17) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-98 94
heparin plasma(n=5) 80-101 81

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Matrix Metalloproteinase 17 (MMP17) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Matrix Metalloproteinase 17 (MMP17) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Matrix Metalloproteinase 17 (MMP17) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-91% 87-98% 96-105% 93-103%
heparin plasma(n=5) 86-101% 85-99% 82-101% 92-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
World Journal of Pediatrics Regulation of JAK/STAT signal pathway by miR-21 in the pathogenesis of juvenile idiopathic arthritis Pubmed: 31641939
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB846Hu01 Recombinant Matrix Metalloproteinase 17 (MMP17) Positive Control; Immunogen; SDS-PAGE; WB.
PAB846Hu01 Polyclonal Antibody to Matrix Metalloproteinase 17 (MMP17) WB; IHC; ICC; IP.
MAB846Hu21 Monoclonal Antibody to Matrix Metalloproteinase 17 (MMP17) WB; IHC; ICC; IP.
SEB846Hu ELISA Kit for Matrix Metalloproteinase 17 (MMP17) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB846Hu Multiplex Assay Kit for Matrix Metalloproteinase 17 (MMP17) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.